Medicare payment rates will drop 4.3% in 2006

September 2005
Urology Times;9/1/2005, Vol. 33 Issue 11, p4
Announces the details of the proposed Medicare Physician Fee Schedule by the Centers for Medicare and Medicaid in the U.S. Proposition of a rule that would lower medical care payment rates; Revisions on payment policies under the proposed rule; Percentage of the reduction required by a statutory formula.


Related Articles

  • Why Pre-set Pricing Could Work. Flower, Joe // Physician Executive;Jul/Aug2007, Vol. 33 Issue 4, p62 

    The author offers his insights regarding the characteristics of the health care sector in the U.S. and in many parts of the world. According to the author, medical care in the U.S. has a pricing structure similar with that of the Soviet Union, wherein prices are determined from the government...

  • Reimbursement reprieve won, but war with CMS continues. Gatty, Bob // Urology Times;Feb2007, Vol. 35 Issue 2, p57 

    The article reports on issues and topics related to the proposed cuts in Medicare reimbursements in the U.S. As one of its final acts in late 2005, the Republican-controlled 109th Congress rolled back a pending 5.1 percent average Medicare fee cut for physicians and paved the way for a new pay...

  • Lifestyle Medicine: An Overview. Dysinger, Wayne S.; Carls, Clara L. // Primary Care Reports;May2010, Vol. 16 Issue 5, p45 

    • The majority of our health care resources are devoted to surgery and medications rather than preventive medicine. • The U.S. overall cost of unhealthy lifestyle has been estimated to reach $100-150 billion annually. • The consensus conference on lifestyle medicine has...

  • VBP: considering the worst case scenario. Alexander, Jim // hfm (Healthcare Financial Management);Jan2008, Vol. 62 Issue 1, p32 

    The article focuses on the possibility of the value-based purchasing (VBP) for hospital and physician services to hold the answer in restraining Medicare spending for the longer short-term in the U.S. According to the author, hospital payments from Reporting Hospital Quality Data for Annual...

  • Medicare Part D: CMS's Process and Policy for Enrolling New Dual-Eligible Beneficiaries: GAO-07-1022T. King, Kathleen M. // GAO Reports;6/21/2007, p1 

    Under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), dual-eligible beneficiaries--individuals with both Medicare and Medicaid coverage--have their drug costs covered under Medicare Part D rather than under state Medicaid programs. The MMA requires the Centers...

  • Measuring Outcomes And Efficiency In Medicare Value-Based Purchasing. Tompkins, Christopher P.; Higgins, Aparna R.; Ritter, Grant A. // Health Affairs;2009 Supplement 1, Vol. 28, pW251 

    The Medicare program may soon adopt value-based purchasing (VBP), in which hospitals could receive incentives that are conditional on meeting specified performance objectives. The authors advocate for a market-oriented framework and direct measures of system-level value that are focused on...

  • Should Drug Prices Be Negotiated Under Part D Of Medicare? And If So, How? Frank, Richard G.; Newhouse, Joseph P. // Health Affairs;Jan/Feb2008, Vol. 27 Issue 1, p33 

    Medicare's Part D prescription drug benefit has offered affordable coverage to millions of elderly Americans since its January 2006 implementation. A great deal of concern has been expressed about whether drugs are being purchased in a cost-effective manner. Many believe that the government...

  • Changes In Medicaid Prescription Volume And Use In The Wake Of Medicare Part D Implementation. Bruen, Brian K.; Miller, Laura M. // Health Affairs;Jan/Feb2008, Vol. 27 Issue 1, p196 

    Implementation of the Medicare drug benefit resulted in a major shift of prescription drug spending from Medicaid to Medicare. Data indicate that Medicaid programs experienced substantial changes in the volume and types of prescriptions used by enrollees. Medicaid prescription volume and total...

  • Drug-price escalation is likely to slow. Toth, David // Fairfield County Business Journal;4/25/2005, Vol. 44 Issue 17, p25 

    The article reports that the Center for Medicare and Medicaid Services (CMS) has stated in a study that although prescription drug spending is at an all-time high, the growth may be slowing and that trend is likely to continue. The high cost of using a brand name medication when a generic brand...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics